These can manifest as an increased risk of thrombotic complications in infection and in type I interferonopathies such as systemic lupus erythematosus (SLE) and STING-associated vasculopathy with onset in infancy (SAVI). This evidence concerns the gene STING1 and STING-associated vasculopathy with onset in infancy.